The concern is how Comey’s testimony and the investigation into Russia’s alleged meddling in the U.S. election will effect Trump’s agenda.

Oliver Pursche, chief market strategist at Bruderman Brothers, believes it is at best a distraction but is more likely something that stalls the Trump agenda, including tax and health-care reform, that the market’s growth has been based on.

“That’s very problematic because we’re not seeing 3 percent plus GDP growth, we’re not seeing strong numbers around the globe. You’ve got oil that fell today,” he said in an interview with “Closing Bell.”

“At this point investors are better to be cautious — tone down risk, stick with high quality stocks, stick with dividend payers, avoid some of the high fliers.”

Bouroudjian agrees.

“If we don’t get this pro-growth agenda passed through, we’re going to have problems,” he said.

He also believes the bond market is signaling there is a problem. The yield on the benchmark 10-year Treasury hit the low of the year on Tuesday.

“It’s very, very difficult to really get bold on this market at this level,” Bouroudjian said.

However, Jim McCaughan, CEO of Principal Global Investors, is still pretty optimistic about U.S. equities.

He believes there will be a continued cycling between different sectors and different stocks, including a possible setback in tech.

“This is a healthy environment in which to be a stock picker in, in which to be buying stocks on setbacks,” he told “Closing Bell.”

—CNBC’s Fred Imbert contributed to this report.